BioHarvest Sciences EBIT 2020-2024 | BHST
BioHarvest Sciences ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
BioHarvest Sciences Annual EBIT
(Millions of US $) |
| 2023 |
$-10 |
| 2022 |
$-11 |
| 2021 |
$-8 |
| 2020 |
$-6 |
| 2019 |
$-2 |
| 2019 |
$-4 |
| 2018 |
$-4 |
BioHarvest Sciences Quarterly EBIT
(Millions of US $) |
| 2024-06-30 |
$-2 |
| 2024-03-31 |
$-1 |
| 2023-12-31 |
$-3 |
| 2023-09-30 |
$-2 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-3 |
| 2022-12-31 |
$-3 |
| 2022-09-30 |
$-3 |
| 2022-06-30 |
$-2 |
| 2022-03-31 |
$-3 |
| 2021-12-31 |
$-1 |
| 2021-09-30 |
$-3 |
| 2021-06-30 |
$-2 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-1 |
| 2020-03-31 |
$-1 |
| 2019-12-31 |
|
| 2019-09-30 |
$-1 |
| 2019-06-30 |
$-0 |
| 2019-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
